Percheron Therapeutics Limited Stock
Stocks
PER
AU0000317281
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Australian S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 0.005000 AUD | +11.11% |
|
+66.67% | -44.44% |
| 03-24 | Polynovo Limited Announces Appointment of Charmaine Gittleson as Non-Executive Director, Effective April 1, 2026 | CI |
| 03-15 | Percheron Therapeutics to raise up to A$2.2 million | RE |
| Market Cap | 7.61M 5.4M 4.66M 4.38M 3.98M 7.49M 516M 51.32M 20.06M 258M 20.26M 19.82M 859M | P/E 2026 * |
-1.32x | P/E 2027 * | -1.06x |
|---|---|---|---|---|---|
| Enterprise Value | 7.61M 5.4M 4.66M 4.38M 3.98M 7.49M 516M 51.32M 20.06M 258M 20.26M 19.82M 859M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.46x |
| Free-Float |
77.3% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +11.11% | ||
| 1 week | +66.67% | ||
| Current month | +66.67% | ||
| 1 month | +66.67% | ||
| 3 months | +25.00% | ||
| 6 months | -37.50% | ||
| Current year | -44.44% |
| 1 week | 0 |  | 0.01 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.01 |
| 3 years | 0 | | 0.14 |
| 5 years | 0 | | 0.35 |
| 10 years | 0 | | 0.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Garner
CEO | Chief Executive Officer | - | 2023-08-06 |
| Director of Finance/CFO | 52 | 2024-06-16 | |
| Chief Tech/Sci/R&D Officer | - | 2025-09-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
Ben Price
BRD | Director/Board Member | 70 | 2021-10-03 |
James Garner
BRD | Director/Board Member | - | 2023-05-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/31/24 | Buy | Chairman | 1,666,666 | 0.1533% | ||
| 12/26/24 | Buy | Chief Executive Officer | 1,500,000 | 0.1379% | ||
| 12/20/24 | Expiration | Chairman | 6,667 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.11% | +66.67% | -47.37% | -90.38% | 5.4M | |
| -1.78% | -1.68% | +1.48% | +15.31% | 48.42B | |
| +0.85% | -0.70% | +460.88% | +563.55% | 43.66B | |
| -2.40% | -0.23% | +8.13% | +71.41% | 39.51B | |
| -2.01% | -0.85% | +23.85% | +8.73% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| -0.59% | -2.06% | +26.35% | +118.09% | 16.15B | |
| +0.49% | +0.92% | +4.11% | +23.67% | 14.16B | |
| -0.43% | +4.70% | +78.74% | +33.31% | 13.37B | |
| Average | +0.51% | +2.94% | +64.08% | +88.15% | 26.31B | |
| Weighted average by Cap. | -0.91% | +0.59% | +95.83% | +132.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 900K 638K 551K 518K 471K 885K 61.01M 6.07M 2.37M 30.55M 2.4M 2.34M 102M |
| Net income | - | - |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | A$0.005000 | +11.11% | 34,691,302 |
| 26-08-13 | A$0.004500 | +12.50% | 1,127,698 |
| 26-08-12 | A$0.004000 | +33.33% | 1,183,384 |
| 26-08-11 | A$0.003000 | -25.00% | 5,969,621 |
| 26-08-10 | A$0.004000 | +33.33% | 25,864,432 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PER Stock
Select your edition
All financial news and data tailored to specific country editions
